The relationship between circulating testosterone and inflammatory cytokines in men

References

• Maggio M, Basaria S, Ceda GP, et al. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest. 2005;28(11 Suppl Proceedings):116–119.
   PubMedGoogle Scholar
• Malkin CJ, Pugh PJ, Jones RD, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89:3313–3318.
   PubMed Web of Science ®Google Scholar
• Nettleship JE, Pugh PJ, Channer KS, et al. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res. 2007;39:366–371.
   PubMed Web of Science ®Google Scholar
• Bobjer J, Katrinaki M, Tsatsanis C, et al. Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS One. 2013;8:e61466.
   PubMed Web of Science ®Google Scholar
• Maggio M, Basaria S, Ble A, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab. 2006;91:345–347.
   PubMed Web of Science ®Google Scholar
• Coelho M, Oliveira T, Fernandes R. State of the art paper Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9:191–200.
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–2556.
   PubMed Web of Science ®Google Scholar
• Fui MNT, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014;16:223–231.
   Web of Science ®Google Scholar
• Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106:S5–S78.
   PubMed Web of Science ®Google Scholar
• Burney BO, Hayes TG, Smiechowska J, et al. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia. J Clin Endocrinol Metab. 2012;97:E700–E709.
   PubMed Web of Science ®Google Scholar
• Grosman H, Fabre B, Mesch V, et al. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer. Aging Male. 2010;13:87–92.
   PubMed Web of Science ®Google Scholar
• Maggio M, Blackford A, Taub D, et al. Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy. J Androl. 2006;27:725–728.
   PubMedGoogle Scholar
• Norata GD, Tibolla G, Seccomandi PM, et al. Dihydrotestosterone decreases tumor necrosis factor-α and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab. 2006;91:546–554.
   PubMed Web of Science ®Google Scholar
• Dandona P, Dhindsa S, Chaudhuri A, et al. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med. 2008;8:816–828.
   PubMedGoogle Scholar
• Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2008;65:S140–S146.
   Web of Science ®Google Scholar
• Kelly DM, Sellers DJ, Woodroofe MN, et al. Effect of testosterone on inflammatory markers in the development of early atherogenesis in the testicular-feminized mouse model. Endocr Res, 2013;38:125–138.
   PubMed Web of Science ®Google Scholar
• Jia YL, Liu X, Yan JY, et al. The alteration of inflammatory markers and apoptosis on chronic prostatitis induced by estrogen and androgen. Int Urol Nephrol. 2015;47:39–46.
   PubMed Web of Science ®Google Scholar
• Papadopoulos AD, Wardlaw SL. Testosterone suppresses the response of the hypothalamic-pituitary-adrenal axis to interleukin-6. Neuroimmunomodulation 2000;8:39–44.
   PubMed Web of Science ®Google Scholar
• Wang M, Tsai BM, Kher A, et al. Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol. Heart Circ Physiol. 2005;288:H221–H226.
   PubMed Web of Science ®Google Scholar
• Demirtas Sahin T, Yazir Y, Utkan T, et al. TNF-alpha antagonism with etanercept enhances penile NOS expression, cavernosal reactivity, and testosterone levels in aged rats. Can J Physiol Pharmacol. 2017;96(2):1–8.
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Johnson-Levonas AO, Lin J, et al. Elevated high sensitivity C-reactive protein levels in aging men with low testosterone. Aging Male. 2010;13:108–112.
   PubMed Web of Science ®Google Scholar
• Kalinchenko SY, Tishova YA, Mskhalaya GJ, et al. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf). 2010;73:602–612.
   PubMed Web of Science ®Google Scholar
• Chin KY, Ima-Nirwana S. The effects of testosterone deficiency and its replacement on inflammatory markers in rats: a Pilot study. Int J Endocrinol Metab. 2017;15:e43053.
   PubMed Web of Science ®Google Scholar
• Ng MK, Liu PY, Williams AJ, et al. Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol. 2002;22:1136–1141.
   PubMed Web of Science ®Google Scholar
• Dougherty RH, Rohrer JL, Hayden D, et al. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels. Clin Endocrinol. 2005;62:228–235.
   PubMed Web of Science ®Google Scholar
• Kapoor D, Clarke S, Stanworth R, et al. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156:595–602.
   PubMed Web of Science ®Google Scholar
• Maggio M, Snyder PJ, De Vita F, et al. Effects of transdermal testosterone treatment on inflammatory markers in elderly males. Endocr Pract. 2014;20:1170–1177.
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Morelli A, Sarchielli E, et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol. 2012;212:71–84.
   PubMed Web of Science ®Google Scholar
• Credit SL, Benghuzzi HA, Tucci M, et al. Localization of cytokines in heart ventricular and apex tissues exposed to sustained delivery of AED, T, and DHT using a rat model. Biomed Sci Instrum. 2002;38:95–100.
   PubMedGoogle Scholar
• Yang Y-M, Lv X-Y, Huang W-D, et al. Study of androgen and atherosclerosis in old-age male. J Zhejiang Univ Sci B. 2005;6:931–935.
   PubMedGoogle Scholar
• Corrales JJ, Almeida M, Burgo R, et al. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J Endocrinol. 2006;189:595–604.
   PubMed Web of Science ®Google Scholar
• Corrales JJ, Almeida M, Miralles JM, et al. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency. Fertil Steril. 2009;92:311–319.
   PubMed Web of Science ®Google Scholar
• Angele MK, Knöferl MW, Ayala A, et al. Testosterone and estrogen differently effect Th1 and Th2 cytokine release following trauma-haemorrhage. Cytokine 2001;16:22–30.
   PubMed Web of Science ®Google Scholar
• Gilliver SC, Ashworth JJ, Mills SJ, et al. Androgens modulate the inflammatory response during acute wound healing. J Cell Sci. 2006;119:722–732.
   PubMed Web of Science ®Google Scholar
• Mendes LO, Scarano WR, Rochel-Maia SS, et al. Testosterone therapy differently regulates the anti- and pro-inflammatory cytokines in the plasma and prostate of rats submitted to chronic ethanol consumption (UChB). Am J Reprod Immunol. 2014;72:317–325.
   PubMed Web of Science ®Google Scholar
• Guo W, Schmidt PJ, Fleming MD, et al. Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation. Endocrinology 2016;157:2937–2946.
   PubMed Web of Science ®Google Scholar
• Patil CN, Wallace K, LaMarca BD, et al. Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration. Am J Physiol Renal Physiol. 2016;311:F395–F403.
   PubMed Web of Science ®Google Scholar
• Poutahidis T, Springer A, Levkovich T, et al. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One. 2014;9:e84877.
   PubMed Web of Science ®Google Scholar
• Kaparianos A, Argyropoulou E, Efremidis G, et al. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study. Eur Rev Med Pharmacol Sci. 2011;15:1149–1157.
   PubMed Web of Science ®Google Scholar
• Bini EI, D’Attilio L, Marquina-Castillo B, et al. The implication of pro-inflammatory cytokines in the impaired production of gonadal androgens by patients with pulmonary tuberculosis. Tuberculosis (Edinb). 2015;95:701–706.
   PubMed Web of Science ®Google Scholar
• Zhao J, Jiang C, Lam TH, et al. Genetically predicted testosterone and systemic inflammation in men: a separate-sample Mendelian randomization analysis in older Chinese men. PLoS One. 2015;10:e0126442.
   PubMed Web of Science ®Google Scholar
• Huang G, Travison T, Maggio M, et al. Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency. Clin Endocrinol. 2016;85:232–238.
   PubMed Web of Science ®Google Scholar
• Saad F, Yassin A, Almehmadi Y, et al. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus–a series of case reports. Aging Male. 2015;18:164–168.
   PubMed Web of Science ®Google Scholar
• Yassin A, Salman M, Talib RA, et al. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male. 2017;20:125–133.
   PubMed Web of Science ®Google Scholar
• Haider A, Gooren L, Padungtod P, et al. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Exp Clin Endocrinol Diabetes. 2009;118:167–171.
   PubMed Web of Science ®Google Scholar
• Crisostomo PR, Wang M, Wairiuko GM, et al. Brief exposure to exogenous testosterone increases death signaling and adversely affects myocardial function after ischemia. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1168–R1174.
   PubMed Web of Science ®Google Scholar
• Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008;78:432–437.
   PubMed Web of Science ®Google Scholar
• Corcoran MP, Meydani M, Lichtenstein AH, et al. Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol. 2010;206:217–224.
   PubMed Web of Science ®Google Scholar
• Bebo BF, Jr., Schuster JC, Vandenbark AA, et al. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol. 1999;162:35–40.
   PubMed Web of Science ®Google Scholar
• Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol. 2001;167:2060–2067.
   PubMed Web of Science ®Google Scholar
• Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest. 1995;95:2886–2895.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Ten RM, Khosla S. The anti‐androgen hydroxyflutamide and androgens inhibit interleukin‐6 production by an androgen‐responsive human osteoblastic cell line. J Bone Miner Res. 1999;14:1330–1337.
   PubMed Web of Science ®Google Scholar
• Shores MM, Smith NL, Forsberg CW, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97:2050–2058.
   PubMed Web of Science ®Google Scholar
• Muraleedharan V, Marsh H, Kapoor D, et al. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol. 2013;169:725–733.
   PubMed Web of Science ®Google Scholar